Biosimilars naming, label transparency and authority of choice -survey findings among European physicians

GaBI Journal

Volumn 3, Issue 2, 2014, Pages 58-62

  Dolinar, Richard O ^a   Reilly, Michael S ^a  

^a ASBM Alliance for Safe Biologic Medicines   (United States)

Author keywords

Biological; Biosimilar; Europe; Inn; Pharmacy substitution; Prescriber

Indexed keywords

EID: 85008248848     PISSN: 20336403     EISSN: 20336772     Source Type: Journal    
DOI: 10.5639/gabij.2014.0302.018     Document Type: Article

References (8)

1. Rovira J, et al. Biosimilars in the European market. Generics and Biosimilars Initiative Journal (GaBI Journal). 2013;2(1):30-5. doi: 10.5639/gabij.2013.0201.012
2. The future of biological therapy: a pathway forward for biosimilars Generics and Biosimilars Initiative Journal, 2013;2(1):36-40. doi: 10.5639/gabij.2013.0201.014
3. GaBI Online - Generics and Biosimilars Initiative. Biosimilars: what physicians need to know [www.gabionline.net]. Mol, Belgium: Pro Pharma Communications International; [cited 2014 May 15]. Available from: www.gabionline.net/Reports/Biosimilars-what-physicians-need-to-know
4. Clayton J. Tighter EU rules on pharmacovigilance for biologicals. Generics and Biosimilars Initiative Journal (GaBI Journal). 2012;1(2):56-7. doi: 10.5639/gabij.2012.0102.015
5. Haustein, et al. Saving money in the European healthcare systems with biosimilars. Generics and Biosimilars Initiative Journal (GaBI Journal). 2012;1(3-4). 120-6. doi: 10.5639/gabij.2012.0103-4.036
6. Thorpe R, Wadhwa M. Terminology for biosimilars-a confusing minefield, Generics and Biosimilars Initiative Journal (GaBI Journal). 2012;1(3-4):132-4. doi: 10.5639/gabij.2012.0103-4.023
7. Alexander E. The biosimilar name debate: what's at stake for public health, Generics and Biosimilars Initiative Journal (GaBI Journal). 2014;3(1):10-2. Doi: 10.5639/gabij.2014.0301.005
8. Dolinar R. WHO leadership in public safety on biosimilars to be commendedGenerics and Biosimilars Initiative Journal (GaBI Journal). 2013;2(4):167. doi: 10.5639/gabij.2013.0204.047